Hippo Signaling Interactive Pathway
Hippo signaling is an evolutionarily conserved pathway that controls organ size by regulating cell proliferation, apoptosis, and stem cell self renewal. In addition, dysregulation of the Hippo pathway contributes to cancer development. Core to the Hippo pathway is a kinase cascade, wherein Mst1/2 (ortholog of Drosophila Hippo) kinases and SAV1 form a complex to phosphorylate and activate LATS1/2. LATS1/2 kinases in turn phosphorylate and inhibit the transcription co-activators YAP and TAZ, two major downstream effectors of the Hippo pathway. When dephosphorylated, YAP/TAZ translocate into the nucleus and interact with TEAD1-4 and other transcription factors to induce expression of genes that promote cell proliferation and inhibit apoptosis. The Hippo pathway is involved in cell contact inhibition, and its activity is regulated at multiple levels: Mst1/2 and LATS1/2 are regulated by upstream molecules such as Merlin, KIBRA, RASSFs, and Ajuba; 14-3-3, α-catenin, AMOT, and ZO-2 retain YAP/TAZ in the cytoplasm, adherens junctions, or tight junctions by binding; Mst1/2 and YAP/TAZ phosphorylation and activity are modulated by phosphatases; Lats1/2 and YAP/TAZ stability are regulated by protein ubiquitination; and LATS1/2 activity is also regulated by the cytoskeleton. Despite extensive study of the Hippo pathway in the past decade, the exact nature of extracellular signals and membrane receptors regulating the Hippo pathway remains elusive.
- Badouel C, McNeill H (2011) SnapShot: The hippo signaling pathway. Cell 145(3), 484–484.e1.
- Genevet A, Tapon N (2011) The Hippo pathway and apico-basal cell polarity. Biochem. J. 436(2), 213–24.
- O'Hayre M, Degese MS, Gutkind JS (2014) Novel insights into G protein and G protein-coupled receptor signaling in cancer. Curr. Opin. Cell Biol. 27, 126–35.
- Pan D (2010) The hippo signaling pathway in development and cancer. Dev. Cell 19(4), 491–505.
- Sudol M, Harvey KF (2010) Modularity in the Hippo signaling pathway. Trends Biochem. Sci. 35(11), 627–33.
- Yu FX, Guan KL (2013) The Hippo pathway: regulators and regulations. Genes Dev. 27(4), 355–71.
- Zhao B, Li L, Lei Q, Guan KL (2010) The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 24(9), 862–74.
- Zhao B, Tumaneng K, Guan KL (2011) The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat. Cell Biol. 13(8), 877–83.
We would like to thank Prof. Kun-Liang Guan, University of California, San Diego, CA for contributing to this diagram.
created November 2010
revised September 2016